# Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology

> **NCT02862054** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis

## Interventions

- **PROCEDURE:** splenectomy

## Key facts

- **NCT ID:** NCT02862054
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862054, "Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02862054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*